Printer Friendly

EG&G PLANS TO ACQUIRE WALLAC GROUP

 Wellesley, Mass., and Stockholm, Sweden, Feb. 9 /PRNewswire/ -- EG&G and Procordia AB announced today they have signed a letter of intent that provides for EG&G to acquire the Wallac Group, a unit of Procordia AB. A definitive agreement, including financial details, is still to be negotiated and is subject to any necessary approvals by governmental authorities and by the boards of directors of both companies.
 The Wallac Group is headquartered in Turku, Finland. Wallac develops, manufactures, and markets analytical and immunodiagnostics systems -- instruments and reagents for clinical diagnostics, life- science research, and environmental monitoring. Wallac's products are marketed through Kabi Pharmacia Diagnostics' and Pharmacia Biotech's international marketing organizations and through local distributors throughout the world. Wallac also operates its own marketing companies in the U.K., the United States, and Scandinavia. Wallac has approximately 500 employees and total sales of approximately U.S. $50 million.
 The acquisition will not only provide analytical instruments which complement existing EG&G businesses, but will also offer an opportunity for EG&G to expand into the diagnostics marketplace.
 EG&G is a Fortune 200 company with annual sales in excess of $2.6 billion. It employs more than 30,000 people in the design and manufacture of laboratory and field-test instruments and electronic and mechanical components for commercial customers worldwide. EG&G provides systems engineering, precision component manufacturing, and test-site operating and management services to many government agencies and laboratories.
 Procordia AB is a diversified world-wide company headquartered in Sweden with 40,000 employees and sales of over 38 billion Swedish kroner in 1991 (approximately U.S. $6.5 billion.) Its activities include Health Care, Foods, Beverages, and other consumer branded products.
 -0- 2/9/93
 /CONTACT: Deborah S. Lorenz, 617-431-4306 of EG&G; Magnus Moliteus of Procordia, Inc., 908-457-8001/
 (EGG)


CO: EG&G; Wallac Group; Procordia AB ST: Massachusetts IN: MTC ARO SU:

ST -- NE006 -- 4497 02/09/93 09:22 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 9, 1993
Words:321
Previous Article:BLUE CROSS AND BLUE SHIELD ANNOUNCES MEMBERS OF NEW CARDIAC NETWORK; NETWORK BASED ON QUALITY & PATIENT OUTCOMES IS FIRST OF KIND IN MINN.
Next Article:DIGITAL'S PATHWORKS AND PC INTEGRATION BUSINESS POST CONTINUED HIGH GROWTH
Topics:


Related Articles
EG&G SIGNS AGREEMENT TO ACQUIRE FINLAND-BASED WALLAC GROUP
EG&G REPORTS THIRD QUARTER EARNINGS
EG&G, INC. REPORTS FOURTH QUARTER EARNINGS
EG&G Will Purchase Life Science Resources Limited.
Executive Briefing.
EG&G: New Management, New Direction, and Perkin-Elmer.
High Throughput Screening Industry Veterans Join IGEN; Company Expands Global Sales and Marketing.
Random Samples.
EG&G Sets Out to Build a New Industry Leader.
PerkinElmer to Sell Berthold.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters